DOP006 A multicentre cohort study to assess the safety of vedolizumab for inflammatory bowel disease
- Resource Type
- Academic Journal
- Authors
- Meserve, J; Aniwan, S; Koliani-Pace, J L; Shashi, P; Weiss, A; Faleck, D; Winters, A; Chablaney, S; Kochhar, G; Boland, B; Singh, S; Hirten, R; Shmidt, E; Bohm, M; Sagi, S V; Fischer, M; Lukin, D; Hudesman, D; Chang, S; Sultan, K; Swaminath, A; Gupta, N; Kane, S; Loftus, E V; Shen, B; Sands, B E; Colombel, J -F; Siegel, C A; Sandborn, W J; Dulai, P S
- Source
- Journal of Crohnʼs and Colitis. Feb 01, 2018 12(supplement_1 Suppl 1):S034-S034
- Subject
- Language
- English
- ISSN
- 1873-9946